55
Participants
Start Date
February 1, 2017
Primary Completion Date
February 1, 2018
Study Completion Date
September 20, 2018
Perflutren Lipid Microsphere Intravenous Suspension
The intravenous administration of Perflutren Lipid Microsphere will provide enhancement of vascular tissue when performing subharmonic prostate ultrasound imaging. This enhancement will be used to guide targeted biopsy of the prostate to vascular areas which are more likely to contain aggressive prostate cancer.
Thomas Jefferson University Hospital, Philadelphia
National Cancer Institute (NCI)
NIH
Thomas Jefferson University
OTHER